Cuentas Inc. (CUENW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 500K 1M 1.5M Q1 '20: 134K Q2 '20: 117K Q3 '20: 134K Q4 '20: 173K Q1 '21: 225K Q2 '21: 155K Q3 '21: 109K Q4 '21: 104K Q1 '22: 394K Q2 '22: 670K Q3 '22: 1.1M Q4 '22: 787K Q1 '23: 64K Q2 '23: 40K Q3 '23: 895K Q4 '23: 1.3M Q1 '24: 639K Q2 '24: 34K Q3 '24: 4K Q4 '24: 0 Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Gross Profit Quarterly

-210K -140K -70K 0 70K 140K 210K Q1 '20: -43K Q2 '20: -91K Q3 '20: -103K Q4 '20: 98K Q1 '21: -22K Q2 '21: 132K Q3 '21: 18K Q4 '21: -4K Q1 '22: 134K Q2 '22: 55K Q3 '22: 116K Q4 '22: 181K Q1 '23: -59K Q2 '23: -113K Q3 '23: -76K Q4 '23: -140K Q1 '24: -69K Q2 '24: -8K Q3 '24: -7K Q4 '24: 9K Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q2 '21: -2M Q3 '21: -2.4M Q4 '21: -4.6M Q1 '22: -3.6M Q2 '22: -3.1M Q3 '22: -2.3M Q4 '22: -5.3M Q1 '23: -1.7M Q2 '23: -893K Q3 '23: -1.2M Q4 '23: -2.6M Q1 '24: -843K Q2 '24: -496K Q3 '24: -306K Q4 '24: -348K Q1 '25: -283K Q2 '25: -320K Q3 '25: -296K Q4 '25: -995K Q1 '26: -333K Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Net Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q2 '21: -2M Q3 '21: -2.4M Q4 '21: -4.6M Q1 '22: -3.6M Q2 '22: -3.2M Q3 '22: -2.3M Q4 '22: -5.4M Q1 '23: -1.7M Q2 '23: -1.4M Q3 '23: -1.2M Q4 '23: 2.1M Q1 '24: -445K Q2 '24: -2.1M Q3 '24: -399K Q4 '24: -393K Q1 '25: -399K Q2 '25: 378K Q3 '25: -296K Q4 '25: -1.3M Q1 '26: -497K Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Cost of Revenue Quarterly

-600K 0 600K 1.2M 1.8M Q1 '20: 177K Q2 '20: 208K Q3 '20: 237K Q4 '20: 77K Q1 '21: 247K Q2 '21: 23K Q3 '21: 91K Q4 '21: 108K Q1 '22: 260K Q2 '22: 615K Q3 '22: 1M Q4 '22: 606K Q1 '23: 123K Q2 '23: 153K Q3 '23: 971K Q4 '23: 1.5M Q1 '24: 708K Q2 '24: 42K Q3 '24: 11K Q4 '24: -9K Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Operating Cash Flow Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q2 '21: -1.4M Q3 '21: -2.5M Q4 '21: -2.1M Q1 '22: -2.2M Q2 '22: -1.9M Q3 '22: -2.4M Q4 '22: -1.6M Q1 '23: -1.5M Q2 '23: -900K Q3 '23: -848K Q4 '23: -992K Q1 '24: -310K Q2 '24: -210K Q3 '24: -72K Q4 '24: -6K Q1 '25: -15K Q2 '25: -951K Q3 '25: -1K Q4 '25: -404K Q1 '26: -190K Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Free Cash Flow Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q1 '11: -18.8K Q2 '11: -15.8K Q3 '11: -821 Q4 '11: -490.3K Q1 '12: -326.2K Q2 '12: -25.9K Q3 '12: -326.5K Q2 '14: -79.8K Q3 '14: -135.7K Q4 '14: -61.9K Q1 '15: -150K Q2 '15: -134.6K Q1 '18: 0 Q2 '18: -114K Q3 '18: -111K Q4 '18: -311K Q1 '22: -2.2M Q2 '22: -1.9M Q3 '22: -2.4M Q4 '22: -1.6M Q2 '11 Q1 '12 Q2 '14 Q1 '15 Q2 '18 Q1 '22 Q4 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q3 '19: 2.2M Q1 '20: 5.3M Q2 '20: 6.2M Q3 '20: 14.1M Q1 '21: 12.5M Q2 '21: 13.4M Q3 '21: 14.9M Q1 '22: 1.2M Q2 '22: 1.2M Q3 '22: 1.2M Q1 '23: 1.7M Q2 '23: 2.1M Q3 '23: 2.2M Q1 '24: 2.7M Q2 '24: 3M Q3 '24: 3M Q1 '25: 2.9M Q2 '25: 2.7M Q3 '25: 2.7M Q1 '26: 5.5M Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q2 '21: -0.96 Q3 '21: -1.00 Q4 '21: -9.31 Q1 '22: -12.33 Q2 '22: -14.94 Q3 '22: -16.62 Q4 '22: -11.87 Q1 '23: -9.72 Q2 '23: -7.63 Q3 '23: -6.32 Q4 '23: -0.95 Q1 '24: -0.10 Q2 '24: -0.13 Q3 '24: 0.27 Q4 '24: -1.22 Q1 '25: -1.22 Q2 '25: -0.38 Q3 '25: -0.36 Q4 '25: -0.53 Q1 '26: -0.47 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.